Results 171 to 180 of about 19,192 (218)

Targeting the mycobiome in sarcoidosis. [PDF]

open access: yesFront Med (Lausanne)
Generalova A   +3 more
europepmc   +1 more source

Evaluation of dimorphic Yarrowia lipolytica strains growth in different culture media by quantitative image analysis [PDF]

open access: yes, 2015
Amaral, A. L.   +4 more
core  

New Yarrowia lipolytica chassis strains for industrial enzyme production. [PDF]

open access: yesMicrob Cell Fact
Onésime D   +4 more
europepmc   +1 more source

Recent trends in microbial production of alkanes. [PDF]

open access: yesWorld J Microbiol Biotechnol
Hagaggi NSA, Abdul-Raouf UM.
europepmc   +1 more source

Yarrowia lipolytica, health benefits for animals

Applied Microbiology and Biotechnology, 2021
The yeast Yarrowia lipolytica has been industrially adopted for docosahexaenoic acid and eicosapentaenoic acid production under good manufacturing practices over 2 decades. In recent years, it has claimed attention for novel biotechnological applications, such as a functional feed additive for animals.
Francisco A. Guardiola   +2 more
openaire   +2 more sources

Yarrowia lipolytica

Yeast, 2012
AbstractThe yeast Yarrowia lipolytica presents specific physiological, metabolic and genomic characteristics, which differentiate it from the model yeast Saccharomyces cerevisiae. These properties have led several research groups to use this yeast as a model for basic knowledge.
openaire   +4 more sources

Fungemia Caused by Yarrowia lipolytica

Mycopathologia, 2015
Yarrowia lipolytica is weakly pathogenic yeast, which is rarely isolated from the blood. We report unusual cases of Y. lipolytica fungemia occurred between October 2012 and June 2014 in the intensive care unit (ICU) of the UH Habib Bourguiba Sfax. During this period, 55 cases of Y. lipolytica septicemia were diagnosed.
H, Trabelsi   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy